Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder
- PMID: 19023831
- PMCID: PMC2764010
- DOI: 10.1080/14622200802443742
Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder
Erratum in
- Nicotine Tob Res. 2009 Sep;11(9):1126
Abstract
Little is known about the impact of alcohol involvement on smoking cessation relapse or possible mechanisms for these associations. We addressed these issues using data from a randomized clinical trial of two types of framed messages (gain vs. loss) in conjunction with open label sustained-release (SR) bupropion (Toll et al., 2007) (N = 249). Participants were categorized according to whether or not they were diagnosed with a lifetime alcohol use disorder (AUD; i.e., current or past alcohol abuse or past alcohol dependence) and according to three levels of alcohol use: abstinence, moderate, or hazardous use. Alcohol use categories were established for drinking at baseline, during the 6-week treatment period and through 12 weeks post-quit. There were few significant differences by baseline alcohol use level or AUD history for a series of predictors of smoking cessation failure (e.g., depressive symptoms). During treatment and follow-up, the probability of any smoking on heavy drinking days was significantly higher than the probability of smoking on moderate drinking or abstinent days. AUD history did not predict smoking cessation relapse in any analysis, nor were any alcohol usexAUD history interactions significant. Moderate alcohol users and, to a lesser extent, abstainers from alcohol at baseline were less likely than hazardous drinkers to have relapsed at 12 weeks post-quit. Based on these findings, it appears that risk of any smoking and of relapse was associated primarily with heavy drinking days and a hazardous pattern of use respectively, rather than with moderate drinking.
Figures


References
-
- Agudo A, Pera G, Rodriguez M, Quiros JR, Navarro C, Martinez C, Larrañaga N, Fernandez A, Dorronsoro M, Chirlaque MD, Berenguer A, Barricarte A, Ardanaz E, Amiano P, Tormo MJ, Gonzalez CA. Changes in smoking habits in adults: Results from a prospective study in Spain. Annals of Epidemiology. 2004;14:235–243. - PubMed
-
- Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. The Journal of the American Medical Association. 2002;288:468–474. - PubMed
-
- Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: A randomized placebo-controlled trial. Addiction. 2004;99:1206–18. - PubMed
-
- Baer JS, Lichtenstein E. Classification and prediction of smoking relapse episodes: An exploration of individual differences. Journal of Consulting and Clinical Psychology. 1988;56:104–110. - PubMed
-
- Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiology Review. 1996;18:188–204. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous